Nanobiotix S.A.

EPA:NANO.PA

4.646 (EUR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q4
Revenue 30.0583.2933.4471.3291.3280.010.0130.0370.0310.0371.4192.061.841.8822.3863.0362.3561.6591.7730.9970.9290.0460.6660.0460.0460.0190.0190.0190.0190.340.340.340.34
Cost of Revenue -2.8570.740.7540.7460.759-1.309-0.864-1.411-0.687-1.78600000000000000000000000
Gross Profit 32.9152.5532.6930.5830.5691.3190.8771.4480.7181.8231.4192.061.841.8822.3863.0362.3561.6591.7730.9970.9290.0460.6660.0460.0460.0190.0190.0190.0190.340.340.340.34
Gross Profit Ratio 1.0950.7750.7810.4390.428131.967.46239.13523.16149.2711111111111111111111111
Reseach & Development Expenses 19.87817.22315.53315.93814.35314.88110.54712.49316.16612.63612.0578.83710.4957.2388.7068.2097.7786.1244.7143.3623.2861.5062.7391.5061.5061.0781.0781.0781.0781.3031.3031.3031.303
General & Administrative Expenses 00000000000000002.8482.8482.2781.7851.34301.8090000000000
Selling & Marketing Expenses 00000000000000000.9990.5590.1980.0540.1900.4080000000000
SG&A 10.97110.6927.9849.4959.018107.7276.4929.7798.866.4536.24.8056.455.4624.93.8483.4072.4761.8391.53302.2160000000000
Other Expenses -0.149-0.0140.025-0.068000.012-0.052-0.05200000000000-4.616-3.583-3.583-3.583-3.583-2.39-2.39-2.39-2.39-2.947-2.947-2.947-2.947
Operating Expenses 30.99827.92923.49225.50123.37124.88118.26219.03725.99721.49618.50914.50215.75614.03414.06813.10111.5989.5447.1865.2034.819-2.0764.956-2.076-2.076-1.312-1.312-1.312-1.312-1.644-1.644-1.644-1.644
Operating Income -1.718-28.669-24.246-26.247-24.13-25.672-19.098-19.906-26.886-22.309-17.09-12.977-13.46-11.806-11.781-10.073-9.27-7.872-5.416-4.203-3.89-2.03-4.289-2.03-2.03-1.294-1.294-1.294-1.294-1.304-1.304-1.304-1.304
Operating Income Ratio -0.057-8.706-7.034-19.749-18.17-2,567.2-1,469.077-538-867.29-602.946-12.044-6.3-7.316-6.273-4.938-3.318-3.934-4.745-3.054-4.214-4.187-43.908-6.436-43.908-43.909-69.788-69.789-69.788-69.789-3.834-3.834-3.834-3.834
Total Other Income Expenses Net -12.101-1.031-9.472-1.1576.286-5.9735.056-1.56-0.767-3.387-0.640.362-0.493-0.3840.07-0.0060.040.0990.1060.0370.025-0.0060.01-0.006-0.006-0.019-0.019-0.019-0.019-0.008-0.008-0.008-0.008
Income Before Tax -13.819-29.7-33.718-27.404-17.844-31.645-14.042-21.466-27.653-25.696-17.73-12.615-13.953-12.19-11.711-10.079-9.23-7.773-5.311-4.166-3.866-2.036-4.279-2.036-2.036-1.313-1.313-1.313-1.313-1.312-1.312-1.312-1.312
Income Before Tax Ratio -0.46-9.019-9.782-20.62-13.437-3,164.5-1,080.154-580.162-892.032-694.486-12.495-6.124-7.584-6.477-4.908-3.32-3.917-4.686-2.995-4.177-4.161-44.041-6.421-44.041-44.042-70.827-70.828-70.827-70.828-3.857-3.857-3.857-3.857
Income Tax Expense -2.218-1.601-3.034-1.047-1.261-1.225-1.031-0.887-0.658-1.77600000.0010.089000.07900.020.0060.0060.0060.0060.020.020.020.020.0080.0080.0080.008
Net Income -11.601-28.099-30.684-26.357-16.583-30.42-13.011-20.579-26.995-23.92-17.73-12.615-13.953-12.19-11.712-10.169-9.23-7.773-5.39-4.166-3.866-2.042-4.279-2.042-2.042-1.333-1.333-1.333-1.333-1.319-1.319-1.319-1.319
Net Income Ratio -0.386-8.533-8.902-19.832-12.487-3,042-1,000.846-556.189-870.806-646.486-12.495-6.124-7.584-6.477-4.908-3.35-3.917-4.686-3.039-4.177-4.161-44.174-6.421-44.174-44.175-71.89-71.891-71.89-71.891-3.88-3.88-3.88-3.88
EPS -0.27-0.8-0.88-0.76-0.48-0.88-0.47-0.91-1.21-1.15-0.91-0.64-0.74-0.76-0.75-0.68-0.69-0.52-0.39-0.35-0.36-0.19-0.4-0.19-0.19-0.16-0.16-0.16-0.16-0.86-0.86-0.86-0.86
EPS Diluted -0.27-0.8-0.88-0.76-0.48-0.88-0.47-0.91-1.21-1.15-0.9-0.64-0.74-0.76-0.75-0.68-0.69-0.52-0.39-0.35-0.36-0.19-0.4-0.19-0.19-0.16-0.16-0.16-0.16-0.86-0.86-0.86-0.86
EBITDA -0.94-27.929-23.492-25.501-23.371-24.871-18.249-19-25.966-21.459-16.856-12.682-13.158-11.654-11.552-9.82-8.972-7.713-5.253-4.059-3.863-1.972-4.083-1.972-1.972-1.257-1.257-1.257-1.257-1.255-1.255-1.255-1.255
EBITDA Ratio -0.031-8.481-6.815-19.188-17.599-2,487.1-1,403.769-513.514-837.613-579.973-11.879-6.156-7.152-6.192-4.842-3.235-3.808-4.65-2.962-4.069-4.158-42.644-6.126-42.644-42.644-67.812-67.813-67.812-67.813-3.689-3.689-3.689-3.689